1. Home
  2. PTCT vs VSAT Comparison

PTCT vs VSAT Comparison

Compare PTCT & VSAT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PTCT
  • VSAT
  • Stock Information
  • Founded
  • PTCT 1998
  • VSAT 1986
  • Country
  • PTCT United States
  • VSAT United States
  • Employees
  • PTCT N/A
  • VSAT N/A
  • Industry
  • PTCT Biotechnology: Pharmaceutical Preparations
  • VSAT Radio And Television Broadcasting And Communications Equipment
  • Sector
  • PTCT Health Care
  • VSAT Technology
  • Exchange
  • PTCT Nasdaq
  • VSAT Nasdaq
  • Market Cap
  • PTCT 4.1B
  • VSAT 4.3B
  • IPO Year
  • PTCT 2013
  • VSAT 1996
  • Fundamental
  • Price
  • PTCT $60.65
  • VSAT $32.36
  • Analyst Decision
  • PTCT Buy
  • VSAT Buy
  • Analyst Count
  • PTCT 14
  • VSAT 8
  • Target Price
  • PTCT $67.00
  • VSAT $22.43
  • AVG Volume (30 Days)
  • PTCT 1.2M
  • VSAT 4.2M
  • Earning Date
  • PTCT 11-06-2025
  • VSAT 11-05-2025
  • Dividend Yield
  • PTCT N/A
  • VSAT N/A
  • EPS Growth
  • PTCT N/A
  • VSAT N/A
  • EPS
  • PTCT 7.72
  • VSAT N/A
  • Revenue
  • PTCT $1,764,929,000.00
  • VSAT $4,564,165,000.00
  • Revenue This Year
  • PTCT $119.89
  • VSAT $5.21
  • Revenue Next Year
  • PTCT N/A
  • VSAT $3.09
  • P/E Ratio
  • PTCT $7.88
  • VSAT N/A
  • Revenue Growth
  • PTCT 96.00
  • VSAT N/A
  • 52 Week Low
  • PTCT $33.88
  • VSAT $6.69
  • 52 Week High
  • PTCT $62.18
  • VSAT $33.85
  • Technical
  • Relative Strength Index (RSI)
  • PTCT 69.46
  • VSAT 62.61
  • Support Level
  • PTCT $58.87
  • VSAT $28.92
  • Resistance Level
  • PTCT $62.18
  • VSAT $33.40
  • Average True Range (ATR)
  • PTCT 2.13
  • VSAT 2.05
  • MACD
  • PTCT 0.52
  • VSAT -0.26
  • Stochastic Oscillator
  • PTCT 88.43
  • VSAT 75.77

About PTCT PTC Therapeutics Inc.

PTC Therapeutics Inc is a biopharmaceutical company that discovers, develops and commercializes clinically differentiated medicines that provide benefits to children and adults living with rare disorders. Its diversified therapeutic portfolio that includes several commercial products and product candidates in various stages of development, including discovery, research and clinical stages, focused on the development of new treatments for multiple therapeutic areas for rare diseases relating to neurology and metabolism. The Company views its operations and manages its business in one operating segment: life science.

About VSAT ViaSat Inc.

Viasat Inc provides bandwidth technologies and services in three segments: communication services and defense and advanced technologies. The communication services segment provides a wide range of broadband and narrowband communications solutions across government and commercial mobility markets, as well as for residential and enterprise fixed broadband customers: and the defense and advanced technologies segment develops and offers a diverse array of resilient, vertically integrated solutions to government and commercial customers, leveraging core technical competencies in encryption, cyber security, tactical gateways, modems and waveforms. A large majority of the firm's revenue is generated from communication services segment.

Share on Social Networks: